Think before you click.
On Tuesday, Feb. 7, 2023, HonorHealth received multiple email messages that were part of a large campaign dubbed “QakNote.” The QakNote campaign was a variation of a previous campaign thatLEARN MORE
Responsible healthcare development in the northeast Valley
As we stated when we acquired the State Land in North Scottsdale last winter, HonorHealth has been very interested in ensuring the responsible development of healthcare capacity in the northeastLEARN MORE
HonorHealth Research Institute is Arizona’s first to adopt new radiation protection technology in treatment of heart disease
Clinical trial at HonorHealth Research Institute shows substantial drop in laboratory radiation, with most cases producing undetectable radiation exposure to cardiology staff HonorHealth Research Institute announced today that it isLEARN MORE
Factor products for surgical patients
Situation Patients with coagulation disorders undergoing surgery often require administration of factor products before or after surgery to prevent post-operative complications, such as bleeding. An opportunity exists to identify theseLEARN MORE
E-Visits now available for patients
E-Visit services are available securely through MyChart for current patients of HonorHealth with non-urgent issues. The service allows patients to get treatment for their medical issue without having to scheduleLEARN MORE
Epic and informatics update
As always, we appreciate each and every one of us being vigilant in opening attachments to emails, and entering usernames and passwords into websites while on the system network. OurLEARN MORE
Update on masking, visitation and COVID-19 precautions
For your safety and the safety of our patients, masking is and continues to be a vital component of HonorHealth’s respiratory virus prevention precautions during times of significant community spread.LEARN MORE
Leadership Update with Dr. John Neil and Kim Post
John Neil, MD, EVP, chief physician executive and network strategy officer, and Kim Post, RN, EVP, chief operations officer, discuss patient experience efforts, caregiver wellness, staffing and financial pressures impactingLEARN MORE
Critical drug shortages
As you know, drug shortages can occur for many reasons, including manufacturing and quality problems, delays and discontinuations. Our goal is to keep you informed about any issues we areLEARN MORE
EVUSHELD COVID-19 monoclonal antibody update
As of Thursday, Jan. 26, 2023, the Federal Drug Administration (FDA) has withdrawn Emergency Use Authorization (EUA) for tixagevimab/cilgavimab (EVUSHELD®) secondary to reduced susceptibility to currently circulating COVID-19 variants. HealthLEARN MORE